Review of HIV-1 Protease Inhibitor Assay Methods

E-ISSN： 1875-676x|3|3|180-185

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.3, Iss.3, 2007-08, pp. : 180-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of atazanavir: a novel HIV protease inhibitor

By Fuster Daniel Clotet Bonaventura

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1565-1572

Informa Healthcare

Access to resources Recommend Favorite

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment

By Barragan Patricia Podzamczer Daniel

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2363-2375

Informa Healthcare

Access to resources Recommend Favorite

Dual protease inhibitor therapy in the management of the HIV-1

By Yu K. Daar E.S.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1331-1342

Informa Healthcare

Access to resources Recommend Favorite

Atazanavir: a novel HIV-1 protease inhibitor

By Piliero Peter J

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1295-1301

Informa Healthcare

Access to resources Recommend Favorite

Resistance to the HIV Protease Inhibitor Amprenavir In Vitro and in Clinical Studies: A Review

By Tisdale M. Myers R. Randall S. Maguire M. Ait-Khaled M. Elston R. Snowden W.

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 267-285

Adis International

Access to resources Recommend Favorite